EUVIMEDEUVIMED entdecken
Multizentrische Studie

Assessment of Breakthrough Cancer Pain Among Female Patients With Cancer: Knowledge, Management and Characterization in the IOPS-MS Study

Anna Crispo, Assunta Luongo, Davide Nocerino, Marco Cascella, Marco Crisci, Francesca Bifulco, Daniela Schiavo, Maurizio Marchesini, Sergio Coluccia, Melania Prete, Alfonso Amore, Egidio Celentano und 2 weitere

Anticancer Research · 2025

DOI: 10.21873/anticanres.17678 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Anticancer Research, 2025. Verfasst von Anna Crispo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Epidemiology and Biostatistics Unit, Istituto Nazionale Tumori, IRCCS Fondazione G. Pascale, Naples, Italy. Hauptthemen laut MEDLINE: Cancer Pain, Breakthrough Pain, Breast Neoplasms, Genital Neoplasms, Female.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Chronic secondary pain from cancer may flare into unexpected acute phases, called breakthrough cancer pain (BTcP). This phenomenon has a moderate-to-severe intensity and short latency between onset and peak of intensity, so clinical and therapeutic implications may be necessary. The Italian Oncologic Pain Multisetting-Multicentric Survey (IOPS-MS) aimed to characterize BTcP in a large number of patients from different settings and assess possible factors influencing its development. Previously, we observed differences according to sex in site, onset and level of BTcP. In this analysis, we assessed differences in non-predictable BTcP between female patients with female-specific cancer (FSC) (including breast and gynecological cancer) and those with non-FSC. PATIENTS AND METHODS: A univariate analysis compared patients with FSC (overall and separately for breast and gynecological cancer) and non-FSC. A multivariate analysis stratified by BTcP phenotype was performed to estimate the main determinants of the risk groups in patients with FSC (overall and separately for breast and gynecological cancer) and non-FSC. Odds ratios and 95% confidence intervals were reported. RESULTS: The FSC group was younger, more often treated in clinics or day hospitals, and had an increased risk of locoregional/metastatic disease than the non-FSC group. Patients with breast cancer were at higher risk of locoregional/metastatic disease, less frequently treated by a palliative specialist and had later BTcP onset compared to the non-FSC group. Significant differences concerning age, care setting and BTcP onset were also found in the group of patients with FSC (overall and separately for breast and gynecological cancer) according to tumor extension. CONCLUSION: Non-predictable BTcP in patients with FSC presents unique characteristics, particularly regarding pain onset, care settings, and metastasis. Differences between breast and gynecological cancer emphasize the need for tailored pain-management approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer PainBreakthrough PainBreast NeoplasmsGenital Neoplasms, FemaleHumansFemaleMiddle AgedAgedItalyAdultPain ManagementPain MeasurementSurveys and Questionnaires

Stichwörter der Autor:innen

BTcPNon-predictable breakthrough cancer painbreast cancercluster analysisgynecological cancer

Autor:innen und Institutionen

  • Epidemiology and Biostatistics Unit, Istituto Nazionale Tumori, IRCCS Fondazione G. Pascale, Naples, Italy.
  • Department of Anesthesia and Critical Care, Istituto Nazionale Tumori, IRCCS Fondazione G. Pascale, Naples, Italy.
  • Anesthesia and Pain Medicine, Scuola Medica Salernitana Department of Medicine, Surgery and Dentistry, University of Salerno, Baronissi, Italy.
  • Department of Anesthesia and Pain Medicine, Mater Olbia Hospital, Olbia, Italy.
  • G.A. Maccacaro Branch of Medical Statistics, Biometry and Epidemiology, Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.
  • Division of Surgery of Melanoma and Skin Cancer, Istituto Nazionale Tumori, IRCCS Fondazione G. Pascale, Naples, Italy.

Zitieren

APA

Crispo, A., Luongo, A., Nocerino, D., Cascella, M., Crisci, M., Bifulco, F., Schiavo, D., Marchesini, M., Coluccia, S., Prete, M., Amore, A., Celentano, E., Bimonte, S., & Cuomo, A. (2025). Assessment of Breakthrough Cancer Pain Among Female Patients With Cancer: Knowledge, Management and Characterization in the IOPS-MS Study. Anticancer Research. https://doi.org/10.21873/anticanres.17678

Vancouver

Crispo A, Luongo A, Nocerino D, Cascella M, Crisci M, Bifulco F, et al. Assessment of Breakthrough Cancer Pain Among Female Patients With Cancer: Knowledge, Management and Characterization in the IOPS-MS Study. Anticancer Research. 2025. doi:10.21873/anticanres.17678

BibTeX
@article{Crispo2025,
  author = {Crispo, Anna and Luongo, Assunta and Nocerino, Davide and Cascella, Marco and Crisci, Marco and Bifulco, Francesca and Schiavo, Daniela and Marchesini, Maurizio and Coluccia, Sergio and Prete, Melania and Amore, Alfonso and Celentano, Egidio and Bimonte, Sabrina and Cuomo, Arturo},
  title = {Assessment of Breakthrough Cancer Pain Among Female Patients With Cancer: Knowledge, Management and Characterization in the IOPS-MS Study},
  journal = {Anticancer Research},
  year = {2025},
  doi = {10.21873/anticanres.17678}
}
Kostenlos starten →